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REVIEW
Abstract: The skin, the largest organ of the body, is the organ in which changes associated
with aging are most visible. With increasing frequency, patients are requesting information
and treatments that improve the appearance of their skin. Corresponding to this trend, there is
an increasing number of products and methods available that claim to aid this pursuit. First, a
change of the patient’s lifestyle (eg, sun behavior, nicotine abuse, and nutrition) must take
place. Only then may other methods be used. This article reflects on the following topics:
topical retinoids, peels, botulinum neurotoxin, soft tissue fillers, lasers, topical and systemic
endocrinological therapies, and phytohormones. A thorough knowledge of the properties
(benefits, limitations, and complications) of the expanding array of possibilities for rejuvenation
of the skin is essential for any physician treating patients with cosmetic complaints.
Keywords: skin aging, topical retinoids, peels, botulinum neurotoxin, soft tissue fillers, lasers,
topical endocrinological therapies, systemic endocrinological therapies, phytohormones
Introduction
The skin is one of the largest organs of the body and, like all other tissues, it undergoes
degenerative processes during aging. The skin represents the major organ in which
aging-related changes are visible (Zouboulis and Boschnakow 2001). Skin aging is
associated with increased rates of skin diseases including skin tumors, and with
concomitant psychological distress caused by the deterioration in appearance.
Although the main focus of public medicine has long been on age-related chronic
diseases of other systems, such as arthritis, heart disease, and cancer (Kligman and
Koblenzer 1997), skin aging and its diseases have become increasingly important.
Most women in developed societies can expect to spend one-third or more of their
lifetime in the postmenopausal period (Kligman and Koblenzer 1997) when the
external signs of aging are of utmost importance for most.
Skin aging is caused by a combination of factors including genetic disposition
and endocrinological background as well as UV light, life habits (nutrition, nicotine,
alcohol, and drugs), catabolic (infections and tumors), and further environmental
factors. Many women notice a sudden onset of signs and symptoms of skin aging
during menopause, such as a rise in skin dryness, loss of firmness, decrease in
elasticity, and increase in skin looseness. There is a connection between these clinical
signs and such phenomena as decrease in collagen and elastin, changes in basic
substance, the ratio of type I/type III collagen, and alterations in vascularization
(Brincat 2000). The external signs of skin aging are reflected in the histopathologic
findings of the skin (Broniarczyk-Dyla and Joss-Wichman 2001).
Dermatology patients are requesting information and treatments to improve the
appearance of their skin with increasing frequency. The number of products and methods
claiming to aid in this pursuit are rising. Many different ways may be helpful. Patients
look for a prompt improvement while physicians emphasize safety and efficacy.
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Sun protection is essential for every age and is a necessary
addition to all other interventions against skin aging.
Chronic low-dose irradiation by the sun causes wrinkles
(Kambayashi et al 2001; Gordon 2005). Ultraviolet
irradiation reduces production of type I procollagen, the
major structural protein in human skin (Quan et al 2004).
To avoid photoaging, it is essential to use sunscreens every
day and to protect one’s skin against UV A and B rays (a
sun protection factor 15 is adequate, but a higher one is
better). In addition, it is also important to use protective
clothing or hats and to avoid the sun wherever possible.
Skin care
Cleansing and moisturizing the skin is important for many
people. Properly cleaned and moisturized skin feels good
to most people and looks better than dry skin. Effective
products are available from most cosmetic companies and
prevent irritant skin reactions and improve barrier functions.
Sun protection, avoidance of cigarette smoke, and balanced
nutrition is essential for the prevention of skin aging.
Topical retinoids
The topical retinoids, tretinoin and tazarotene, improve
mottled hyperpigmentation, fine wrinkles, roughness, and
lentigines (Kligman et al 1986; Kang et al 2001; Weiss
2005). One problem is skin irritation. To minimize this
problem, it is useful to start with a relatively mild
concentration of topical retinoids. If this is not enough,
patients should reduce the application frequency. The aim
must be to use the highest concentration that can be tolerated
without significant irritation of the skin.
Peels
There are three categories of peels: deep peels (eg, phenol
peel), medium peels (eg, 30% trichloracetic acid peel), and
superficial peels (eg, alpha hydroxyl and salicylic acid peel).
Creams with alpha hydroxyl and salicylic acid are also
available for the everyday use of the patient. Depending on
the depth of the peel, peels remove the uppermost layers of
the skin.
Botulinum neurotoxin
Botulinum neurotoxin is a paralysing substance. It is used
for softening glabellar frown lines, horizontal forehead lines,
crow’s feet, perioral smile lines, platysmal bands of the neck,
and to elevate the eyebrows and lateral corners of the mouth
(Gordon 2005).
A careful history should be taken to avoid complicating
neurologic problems or the ingestion of medications that
may interfere with the toxin. The toxin diffuses about
1 cm–1.5 cm from the injection site. This must be considered
to avoid eyelid ptosis, for example. The patient should not
manipulate the treated area after treatment to avoid
unintended diffusion of the toxin. The contraction of the
treated muscles after treatment may increase toxin uptake
and increase the effectiveness of treatment. The effect of
the toxin is seen after about a week.
Soft tissue fillers
Physicians have been searching for the ideal filler for more
than a century. The use of injected paraffin for cosmetic
purposes more than 100 years ago resulted in paraffinomas
(Murray et al 2005). Many substances are available today.
Collagens
Collagen is a fibrous, extracellular, insoluble protein
comprising a major component of connective tissues.
Injectable collagen consists of varying concentrations of
highly purifed bovine or human collagen. Sensitivity
reactions and granulomatous responses have occurred in
1%–3% and 0.5% of patients, respectively (Cooperman et
al 1985). Minor side effects such as bruising, redness, and
swelling are seen after injection, but tend to resolve after a
few days. Reimplantation is usually required in 3–6 months.
Bovine collagen
Bovine collagen is available in several formulations for fine
lines as well as for deeper lines and folds. Patients must be
allergy tested because of the possibility of rare allergic
reactions. Two tests must be performed 3 weeks apart and
treatment cannot be started until 3–4 weeks after the second
allergy test.
Human-based collagen
No allergy testing is required.
Hyaluronic acid
Hyaluronic acid is a component of all connective tissues
and is abundant in the human dermis. It is a naturally
occurring glycosaminoglycan biopolymer, which provides
a fluid matrix or lattice on which collagen and elastic fibers
may develop. Its hydrophilic nature attracts and retains waterClinical Interventions in Aging 2006:1(1) 53
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(Pollack 1999). The incidence of allergic reactions is so low
that no allergy testing is required. Corrections with
hyaluronic acid generally last longer than with collagen.
There are also several formulations for fine to deep lines.
There are products that are manufactured through bacterial
fermentation and there are others that are extracted from
rooster combs. Patients using the latter must not have an
allergy to avian products.
Unusual hypersensitivity and granulomatous foreign
body reactions have been reported, but hyaluronic acids are
generally safe and practical and need no allergy testing
(Murray et al 2005).
Autologous fat
Neuber introduced the use of autologous fat for tissue
augmentation in 1893 (Neuber 1893). Over the years, the
popularity of Neuber’s method has grown, but there is still
no evidence-based gold standard method around. The
longest lasting results are seen when used for atrophic skin
conditions. Adverse events, such as fat necrosis, are
temporary but not uncommon.
Allogenic products
Allogenic material is either obtained from cadaveric dermis
or fascia, or engineered by methods using human cell lines
and has a high biocompatibility with low antigenicity. These
products are similar to the bovine collagens in indication
and technique, but do not require allergy tests and have a
shorter longevity.
Synthetic products
The production of synthetic products is cheaper and they
are semipermanent or permanent implants. One of the first
synthetic fillers was silicone. Today there are several
substances available such as polylactic acid, polyalkylamide,
polyacrylamide, and polytetrafluoroethylene. Adverse
reactions with these agents can be serious.
Lasers
Laser is the acronym for “light amplification by the
stimulated emission of radiation”. Schawlow and Townes
developed the first laser in 1958 (DiBernardo and Cacciarelli
2005). Lasers use light at various frequencies to attain a
specific clinical result. They can be categorized by the
medium in which the light energy is produced. Mechanisms
of action include selective thermolysis and specific cell
stimulation while leaving normal tissue unaffected. The
immune system clears the unwanted material. Lasers can
be used to cut, destroy, cauterize, and vaporize tissue.
Dermatological indications are skin rejuvenation, tattoo
removal, hair removal, and improvement in various skin
abnormalities. For example, an ablative laser such as CO2
or erbium would be considered for skin rejuvenation.
Complications could be pigment changes, superficial skin
changes, scarring, infection, bleeding, and accidential eye
injury.
Surgical procedures
There are many methods of cosmetic surgery such as
facelifts not covered by this article. Space limitations
preclude an extensive discussion of this field.
Endocrinological therapies for skin
aging
Skin is a target organ for various hormones (Zouboulis
2000). Sex steroids have a profound influence on both skin
development and composition; adequate levels are required
to facilitate its structural integrity and functional capacity
(Raine-Fenning et al 2003). Hormonal action requires the
binding of the hormone to specific receptors (Zouboulis
2000). Estrogen and other hormone receptors have been
detected, inter alia, in keratinocytes, fibroblasts, sebaceous
glands, hair follicles, endocrine glands, and blood vessels
(Schmidt et al 1990). The receptors vary in density according
to site, with higher concentrations of estrogen receptors in
facial skin than in the skin at the pelvis or breast. Decreased
sex hormones thus induce a reduction of those skin functions
that are under hormonal control.
In clinical terms, many females experience a sudden
onset of skin aging symptoms several months after
menopause. One of the first signs which women experience
is increasing skin dryness followed by a loss of skin firmness
and elasticity. The increasing looseness of the skin at that
stage outweighs other symptoms such as wrinkles. These
symptoms correspond to changes in collagenous and elastic
fibers that have been reported to be due to estrogen
deficiency (Schmidt et al 1994). A significant decrease in
skin collagen starting at menopause has previously been
demonstrated (Castelo-Branco et al 1992). This negative
effect of the menopausal years on the skin was first described
by Albright in 1940, who noted that older women with
osteoporotic fractures had a higher incidence of altered skin
(Albright et al 1940). Among the various types of collagen,
types I and III are of major relevance. Type I collagenClinical Interventions in Aging 2006:1(1) 54
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represents the predominant collagen type in adult human
skin whereas type III collagen, also widely distributed
throughout the body, predominates in fetal tissues. Both total
collagen content and the ratio of type III to type I collagen
decline with age (Sawas et al 1993). Skin collagen contents
in adults decreases by 1% every year (Shuster et al 1985).
This process is more evident in women than in men.
Approximately 30% of skin collagen is lost in the first five
years after menopause, with an average decline of 2.1% per
postmenopausal year over a period of 20 years. Estrogens
reverse this trend and increase skin collagen (Zouboulis
2000). Estrogens also enhance the synthesis of hyaluronic
acid and promote water retention (Epstein and Munderloh
1975). Animal studies indicate that estrogens induce several
changes in the connective tissue of the dermis, including
increased mucopolysaccharide incorporation, hydroxy-
proline turnover, and alterations in the extracellular matrix
(Holland et al 1994).
Epidermal cells – keratinocytes, Langerhans’ cells, and
melanocytes – are also target cells of steroid hormones
(Zouboulis 2000). The estrogen receptor complex is able to
support the expression of growth factors such as insulin-
like growth factor type one (IGF-I), a mitosis-enhancing
protein for keratinocytes (Tavakkol et al 1999). The
Langerhans’ cells are influenced by progesterone, with their
number increasing during the luteal phase. Melanocytes are
stimulated by 17β-estradiol (Gruber et al 2002).
Sex steroids are involved in many extragenital organ
systems such as the urogenital tract, skin and hair, breast,
and cardiovascular, nervous, or skeletal systems. Con-
sidering that most women spend one-third of their lives with
estrogen deficiency, the potential field of action for hormone
replacement therapy (HRT) is becoming increasingly larger.
Topical treatment
A placebo-controlled study examined the effect of a topically
applied conjugated estrogen skin care cream (Premarin
®
0.625 mg/g ointment) in 54 women (Creidi et al 1994).
Evaluation criteria were profilometry and measurements of
skin thickness by ultrasound. After a 24-week treatment
period there was a significant increase in skin thickness in
the Premarin® group as compared to the placebo group. Even
in regard to small wrinkles, a significant reduction was
observed in comparison to the placebo group after 12 and
24 weeks. No side effects were found.
A study was published on the action of topical 0.3%
estriol and 0.01% 17β-estradiol in 59 patients (Schmidt et
al 1996). The criteria evaluated by the authors were
profilometry, corneometry, and clinical signs. Wrinkle depth
was significantly reduced and skin hydration was improved.
Apart from a rise in prolactin, no other systemic hormonal
effects were detected. Histological tests of collagen
parameters in 10 patients showed a significant increase in
the collagen III fraction at the end of therapy after 24 weeks.
In a recent study, the effects of a 0.01% 17β-estradiol
cream were compared with those of a 15% glycolic acid
cream and a combination of both (Fuchs et al 2003). The
effects examined in 65 patients after 6 months indicated an
increase in epidermal thickness and were most marked in
the combination group (38%), followed by the glycolic acid
group (27%), and the 17β-estradiol group (23%).
Systemic hormone replacement therapy
A HRT consists of two components: estrogens and
progestagens. Estrogens administered as monotherapy may
result in undesired hyperplasia of the endometrium. To avoid
this event, synthetic derivatives of progesterone and
testosterone, known as progestagens, are combined with an
estrogen compound and may be applied in a cyclical or
continuous mode. An estrogen monotherapy is feasible in
hysterectomized women, with a choice of oral, transdermal,
and vaginal forms of application available.
Beneficial effects of HRT on the skin have been
documented by several studies in respect of skin thickness
as a mirror image of collagen content (Brincat et al 1987;
Maheux et al 1994; Dunn et al 1997; Sator, Sator, et al 2001).
A large retrospective multi-center study, NHANES I,
conducted in 3825 women in the USA, showed that women
under long-term substitution had one-third fewer wrinkles
than non-substituted patients (Dunn et al 1997). Post-
menopausal women with an HRT had significantly higher
collagen content than untreated women (Brincat et al 1987).
One study examined the effects of three types of HRT
in terms of skin aging in menopausal women (Sator,
Schmidt, et al 2001): one group was given estrogen only
via the transdermal route (Estraderm TTS® 50), the second
group received estrogen by transdermal application in
combination with vaginally applied progesterone (Estraderm
TTS
® 50 and 0.4 g progesterone vaginal suppository), and
the third group was administered oral estrogen and vaginal
progesterone (2 mg Progynova
® and 0.4 g progesterone
vaginal suppository). One group without treatment served
as a control. Treatment was continued for 6 months. Skin
surface lipids, epidermal skin hydration, skin elasticity, and
skin thickness were measured at monthly intervals. Mean
levels of epidermal skin hydration, elasticity, and skinClinical Interventions in Aging 2006:1(1) 55
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thickness were improved at the end of treatment based on
both subjective and objective evaluation in patients with
HRT. Skin surface lipids were increased during combined
HRT, which may reflect stimulatory effects of the
progestagen component on sebaceous gland activity, while
estrogen alone has a sebum-suppressive action (Zouboulis
2001). A comparison of skin hydration and elasticity in UV-
exposed and non-exposed areas revealed no significant
difference. This finding suggests that both photoaged and
UV-protected skin benefit equally from HRT. These results
were confirmed by animal tests using the skin of rats
(Tsukahara et al 2001).
Although the majority of publications consider the
influence of HRT on skin aging to be positive, there are
some authors who doubt or reject any effect of hormone
replacement on skin thickness, collagen synthesis, or elastin
(Oikarinen 2000).
Alternatives: phytohormones
The estrogen-like effects of some plants were first described
in 1926 (Loewe et al 1927). Phytoestrogens are classified
in three categories: isoflavones, coumestans, and lignans.
The most thoroughly examined group of substances are
isoflavones, which display some similarity to the mammal
estrogen molecule and are found, inter alia, in soy, beans,
lentils, and red clover. Flavonoids are also contained in wine,
especially red wine. The most important isoflavones are
genistein and daidecin. The group also includes the
precursors formonontein (for daidecin) and biochanin (for
genistein). Coumestans only occur in the sprouts of legumes.
Lignans have no influence on estrogen receptors. The
structural similarity to 17β-estradiol explains the estrogen-
like effects, which may be traced back to the interaction of
these substances with the estrogen receptor (Wang et al
1996). Nutrition in Asian countries, with its large
phytoestrogen content, is thought to be the reason why Asian
women rarely suffer from climacteric symptoms. The
biological potency of isoflavonoids is significantly inferior
to that of synthetic estrogens (Markieicz et al 1993). When
phytoestrogens are topically applied, they behave like
estrogens by causing a proliferation of the epidermis,
supporting collagen synthesis and reducing enzymatic
collagen degradation.
A controlled open European multicenter study examined
the effect of a cosmetic cream preparation including
isoflavone (Novadiol
®) on 234 women: maximum age 65
years, at least 3 years since menopause, no HRT or other
substances affecting the skin aging process (Bayerl and Keil
2002). The length of therapy was 12 weeks. The isoflavone
cream was applied two times daily (in the morning with a
concentration of 0.0075% isoflavone and in the evening with
a concentration of 0.015% isoflavone) on the face, neck,
and one upper arm. The other arm was untreated and served
as a control. Skin dryness and roughness were significantly
improved at the treated areas by 32.9% and 22%,
respectively, in comparison with the untreated skin areas.
Facial wrinkles were significantly reduced by 22% and skin
looseness was significantly reduced by 24%.
Summary of hormonal therapies
Numerous publications on the effects of sex hormones on
the aging process are available today. Without claiming that
HRT can or should ever be regarded as an independent
treatment of skin aging, these findings are still interesting
to note, considering that they indicate a beneficial effect of
HRT on the skin despite the fact that the results of the “WHI-
Study” (Rossouw et al 2002) and the “Million Women
Study” (Beral 2003) have shown negative effects of HRT
on other organs. What is clear is that HRT must be rejected
when it is solely considered for the prevention of skin aging.
As an additional benefit in the treatment of menopausal
conditions provided by a dermatologist with sufficient
experience in the discipline of endocrinology, however, it
is a very effective instrument to control intrinsic skin aging.
While the topical application of hormones is certainly a
suitable alternative to a systemic HRT, it must be ensured
that such a treatment is also administered by a dermatologist
experienced in endocrinology given that concentrations and
application areas need to be observed in order to avoid
systemic side effects.
Phytoestrogens, topical and systemic, appear to be an
effective method in the treatment of intrinsic skin aging.
However, further data are still required, especially from
controlled studies on long-term results of systemic
application.
Conclusion
An increasing number of products and procedures exists to
promote youthful skin. First, a change of the lifestyle (eg,
sun behavior, nicotine abuse, nutrition) of the patient must
take place. Only then can other methods be used. A thorough
knowledge of the properties (benefits, limitations, and
complications) of the ever-expanding array of possibilities
for rejuvenation of the skin is essential for any physician
treating patients with cosmetic complaints.Clinical Interventions in Aging 2006:1(1) 56
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